Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Carnitine vs Sildenafil in Beta Thalassemia with Increased TRJV
NCT05584956Phase 3Unknown
- Sponsor
- Tanta University
- Start
- Jul 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levocarnitine, sildenafil in beta thalassemia, sponsored by Tanta University. Status: unknown.
02
Drugs
levocarnitinesildenafil
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT05584956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05584956.